
Loading, please wait...

Loading, please wait...

Meningiomas in children represent exceptionally rare intracranial neoplasms that diverge dramatically from their benign adult counterparts. Although adult lesions generally follow an indolent clinical course, pediatric meningiomas frequently demonstrate aggressive histopathological features and rapid progression. Clinicians historically relied on aggressive microvascular craniotomy for primary disease control. However, complete surgical resection often remains elusive due to intricate skull base localization. Consequently, neurosurgeons increasingly utilize Gamma Knife stereotactic radiosurgery as a targeted non-invasive alternative or adjuvant tool. Evaluating long-term survival, local control, and post-treatment toxicity provides crucial guidance for pediatric neuro-oncology teams worldwide.
Pediatric meningiomas account for less than two percent of all pediatric central nervous system neoplasms. Moreover, they represent an exceedingly small subset of all diagnosed meningiomas across all age demographics. Unlike the female-predominant distribution observed in older adults, childhood meningiomas show a slight male predilection. Furthermore, pediatric cases frequently correlate with genetic predisposition syndromes, particularly neurofibromatosis type 2. Prior exposure to therapeutic cranial irradiation or total body irradiation also serves as a potent secondary trigger.
Pathologists often identify atypical or anaplastic histology in children more frequently than in adult populations. Specifically, childhood tumors often exhibit high mitotic activity, sheet-like growth, brain invasion, and focal necrosis. These biological characteristics translate into significantly elevated risks of local recurrence following primary surgical resection. Additionally, pediatric patients frequently develop intraventricular or skull base lesions that preclude complete resection. As a result, pediatric neuro-oncologists must balance tumor extirpation against the preservation of lifelong neurological function. Therefore, stereotactic radiosurgery provides an essential, tissue-sparing adjunct within the modern neurosurgical armamentarium.
To clarify the clinical efficacy of focused radiosurgery, researchers at the University of Pittsburgh Medical Center evaluated their comprehensive 35-year experience. Among 2,030 total patients who received stereotactic radiosurgery for meningiomas, investigators identified exactly nine pediatric patients. This minute cohort represents an institutional incidence rate of only 0.44 percent, underscoring the extreme rarity of this entity. The patient cohort comprised seven males and two females, with a median age of 14.5 years at treatment.
Notably, three children in this series had a documented history of prior total body irradiation for hematological malignancies. Most patients presented asymptomatically for radiosurgery because routine surveillance neuroimaging detected their tumors early. Prior to radiosurgery, seven of the nine patients had undergone at least one microsurgical craniotomy for decompression. Furthermore, two patients had previously completed conventional fractionated external beam radiotherapy. Across the treated cohort, the median cumulative tumor volume measured 3.65 cubic centimeters. Clinicians treated these distinct targets with a median peripheral margin radiation dose of 14 Gray. Consequently, this cohort provides valuable real-world insight into long-term radiosurgical management.
Stereotactic radiosurgery delivers steep dose gradients that sharply sculpt radiation fields to complex anatomical targets. In the Pittsburgh cohort, treated tumor volumes ranged widely from 0.01 to 11.84 cubic centimeters. Radiosurgeons prescribed margin doses between 11 and 25 Gray to optimize cell kill while limiting neurotoxicity. The median follow-up period extended to 107 months, providing substantial longitudinal surveillance exceeding eight years.
During the initial post-radiosurgical period, Gamma Knife therapy demonstrated excellent efficacy. Actuarial local tumor control reached 100 percent at the one-year follow-up milestone. However, tumor control declined to 55.6 percent at five years and stabilized at 55.6 percent at ten years. Five of the nine children experienced verified local tumor recurrence at a median duration of 25 months post-radiosurgery. These findings illustrate a marked contrast to adult cohorts, where radiosurgery routinely achieves five-year control rates above 85 percent. Consequently, pediatric clinicians must recognize that the aggressive biology of young tumors can overcome stereotactic radiation doses. Therefore, high-resolution neuroimaging surveillance remains essential throughout childhood, adolescence, and early adulthood.
When local control failed in the study cohort, multidisciplinary teams quickly deployed aggressive salvage interventions to curb progression. Specifically, two patients underwent repeat Gamma Knife radiosurgery to restabilize progressive tumor margins. Meanwhile, two other patients required repeat open craniotomies for microvascular surgical debulking. Clinicians placed another patient with an unresectable enlarging mass on chronic systemically administered hydroxyurea therapy. These diverse rescue strategies highlight the indispensable role of adaptive multimodal decision-making in refractory pediatric neuro-oncology.
Despite rigorous surveillance and multimodality interventions, intracranial disease progression caused four patient deaths during the extended follow-up window. Five patients remained alive at their latest clinical follow-up examination. Actuarial overall survival reached 100 percent at one year, 88.9 percent at five years, and 64.8 percent at ten years. The primary driver of late mortality was uncontrolled intracranial tumor proliferation rather than radiation-induced secondary malignancies. Thus, while radiosurgery affords meaningful disease stabilization, persistent malignant propensity necessitates unyielding vigilance. Physicians must educate families about the chronicity of disease monitoring and prepare for potential secondary therapies.
The findings from this landmark 35-year study deliver crucial guidance for neurosurgeons, pediatric oncologists, and radiation oncologists. First, clinicians should consider stereotactic radiosurgery as an upfront or adjuvant modality when tumor anatomy precludes safe complete surgical resection. Radiosurgery successfully avoids the immediate morbidity associated with extensive skull base dissections in delicate pediatric tissues. In addition, stereotactic delivery substantially reduces integrated whole-brain radiation doses compared to conventional radiotherapy, thereby preserving developing cognitive networks.
Second, multidisciplinary teams cannot extrapolate adult meningioma outcomes to young children. Pediatric meningiomas exhibit distinct genomic signatures, higher proliferation indices, and elevated rates of aggressive histopathological subtypes. Accordingly, clinical teams must establish rigorous post-radiosurgical monitoring protocols featuring frequent contrast-enhanced imaging. Early detection allows prompt salvage therapy, including repeat radiosurgery, surgical re-resection, or novel systemic therapies. Emerging pharmacological agents, such as MEK inhibitors and targeted biological therapies, offer promising avenues for syndromic or progressive cases. Simultaneously, developing international multi-institutional registries will help refine optimal radiation dosages and fractionation protocols. Ultimately, integrating stereotactic radiosurgery into disciplined multimodal care models maximizes tumor control while preserving essential quality of life for young patients.
Pediatric meningiomas represent less than two percent of all childhood intracranial neoplasms, contrasting sharply with adults where meningiomas constitute over one-third of primary brain tumors. Children also lack the typical female predilection seen in adults. Furthermore, childhood cases frequently link to genetic syndromes or previous cranial radiotherapy exposure.
Radiation oncologists and neurosurgeons typically prescribe peripheral margin doses between 11 and 15 Gray for pediatric meningiomas. Clinicians carefully adjust these dosimetric parameters based on cumulative tumor volume, adjacent critical structures, and previous radiation history to balance local tumor control against potential long-term neurocognitive toxicity.
Pediatric meningiomas exhibit significantly higher rates of aggressive histopathological features, including elevated mitotic activity, atypical classification, and brain invasion. These aggressive cellular kinetics render pediatric lesions inherently more radioresistant and prone to recurrence, resulting in lower ten-year local control rates compared to typical adult meningiomas.
Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional regarding clinical decisions or conditions. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A landmark 35-year study from UPMC evaluates the efficacy, safety, and long-term survival outcomes of Gamma Knife stereotactic radiosurgery in pediatric meningiomas, highlighting unique clinical considerations and the necessity of multimodal salvage strategies for aggressive childhood intracranial tumors.
Today

A qualitative study evaluated the INCLUDE trial, a culturally tailored mobile diabetes prevention intervention. Findings highlight digital accessibility and community coaching as key facilitators, while time constraints and rigid dietary elements posed barriers, offering vital lessons for clinical practice.
Today

A large cohort study demonstrates that fetal growth restriction in a first pregnancy raises maternal cardiovascular risk within five years postpartum, including elevated rates of heart failure, stroke, and myocardial infarction. Clinicians must initiate proactive postpartum screening and cardiovascular prevention.
Today

An NHANES analysis reveals that meeting 24-hour movement guidelines significantly lowers the odds of cardiovascular disease, obesity, hypertension, and diabetes among adults with disabilities, emphasizing the power of combined physical activity, sleep, and limited sedentary time.
Today

A paired cadaveric study compared triple and quintuple percutaneous Achilles tendon lengthening. While quintuple hemisection showed numerically greater elongation, differences were not statistically significant.
Today

A randomized trial in California evaluated a grocery support program for low-income, chronically ill adults. The intervention improved nutrition security by 2.8%, increased vegetable intake, boosted mental health scores, and reduced cost-related healthcare delays by 3.8%, showing the power of food-as-medicine.
Today